Barclays
RGEN icon

Barclays’s Repligen RGEN Stock Holding History

Barclays’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,000
Closed -$2.67M – 5602
2025
Q3 		$2.67M Sell
20,000
-60,000
-75% -$7.29M ﹤0.01% 2658
2025
Q2 		$10M Buy
80,000
+10,000
+14% +$1.27M ﹤0.01% 1589
2025
Q1 		$8.91M Buy
70,000
+50,000
+250% +$7.7M ﹤0.01% 1488
2024
Q4 		$2.88M Buy
+20,000
New +$2.87M ﹤0.01% 2616
2017
Q3 		– Sell
-40,000
Closed -$1.66M – 7008
2017
Q2 		$1.66M Hold
40,000
– – ﹤0.01% 2419
2017
Q1 		$1.41M Buy
+40,000
New +$1.27M ﹤0.01% 2415

Other funds holding RGEN

William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Conestoga Capital Advisors
Conestoga Capital Advisors Wayne, Pennsylvania $3.31B AUM 6.07% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Barclays's RGEN Position: Q3 2026 in Review

Barclays increased its Repligen (RGEN) stake by 129% in Q3 2026, buying an estimated $32.6M and bringing the position to 356,419 shares worth $68.5M. The position accounts for 0.01% of the portfolio, ranked #661.

Barclays first reported a position in RGEN in Q2 2013 and has held it in 54 quarters since. 223 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Barclays held 356,419 shares of Repligen worth $68.5M as of Q3 2026.
  • Barclays bought 200,674 Repligen shares in Q3 2026, an estimated $32.6M.
  • Repligen made up 0.01% of Barclays's portfolio in Q3 2026, its #661 holding.
  • Barclays first reported a position in Repligen in Q2 2013 and has held it in 54 quarters since.
  • 223 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.